LeafyColl Ltd Secures $192K Grant Round

LeafyColl Ltd has secured $192,000 in its latest funding round, positioning the company to advance its plant-made collagen technology. The company specializes in developing innovative, entirely plant-derived collagen solutions designed to support women's health and skin. Their unique approach uses revolutionary bioengineering to transform plants into 'collagen factories,' enabling the natural production of 100% bio-identical human collagen proteins. This funding round is significant as LeafyColl addresses a market where traditional collagen sources from fish or bovine present various limitations, including allergic reactions, disease risks, and incomplete collagen types. Furthermore, many existing 'vegan collagen' products are often misleading, consisting of plant ingredients that merely claim to boost collagen rather than being actual collagen. LeafyColl's technology offers a complete and sustainable alternative by producing all types of collagen, from Type 1 to Type 3, entirely bypassing animal sources. The newly acquired capital will be used to accelerate the company’s growth initiatives, including further product development and scaling its production capabilities. This investment is crucial for LeafyColl as it moves towards commercializing its net-zero vegan collagen for the global market. The company aims to make premium, affordable beauty and healthcare accessible while also protecting the environment. LeafyColl Ltd is focused on expanding its reach and impact within the beauty and healthcare sectors. The company's innovative plant-made collagen solution is poised to offer a compelling, sustainable, and effective option for consumers seeking real collagen results without relying on animal-derived products.